DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Meprobamate (Meprobamate) - Summary

 
 



MEPROBAMATE SUMMARY

Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.

Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.

The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.


See all Meprobamate indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Meprobamate

Women-Only Cardiac Rehab May Alleviate Anxiety, Depression
Source: Medscape Medical News Headlines [2016.02.05]
Although behavioral and psychosocial outcomes were “largely equivalent” regardless of model, women-only programs "may confer an advantage for anxiety and depressive symptoms," write the researchers.
Heartwire from Medscape

Anxiety disorder 3 times more likely among older adults with COPD
Source: Anxiety / Stress News From Medical News Today [2016.02.04]
Older adults with COPD who were exposed to parental domestic violence in childhood were 5 times more likely to have generalized anxiety disorder.

Meditation May Ease Pain, Anxiety From Breast Cancer Biopsy: Study
Source: MedicineNet Cancer Specialty [2016.02.04]
Title: Meditation May Ease Pain, Anxiety From Breast Cancer Biopsy: Study
Category: Health News
Created: 2/4/2016 12:00:00 AM
Last Editorial Review: 2/4/2016 12:00:00 AM

Anxiety Meds Like Valium, Xanax Won't Raise Seniors' Dementia Risk: Study
Source: MedicineNet Dementia Specialty [2016.02.04]
Title: Anxiety Meds Like Valium, Xanax Won't Raise Seniors' Dementia Risk: Study
Category: Health News
Created: 2/3/2016 12:00:00 AM
Last Editorial Review: 2/4/2016 12:00:00 AM

Reduced anxiety and depression for women participating in women-only cardiac rehab programs
Source: Anxiety / Stress News From Medical News Today [2016.02.03]
Cardiovascular disease is the leading cause of death for women globally. Women who have an acute coronary heart event may be more likely to die or to suffer complications during the initial...

more news >>

Published Studies Related to Meprobamate

Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).

more studies >>

Reports of Suspected Meprobamate Side Effects

Toxicity TO Various Agents (28)Respiratory Arrest (15)Cardiac Arrest (15)Accidental Death (14)Drug Abuse (11)Completed Suicide (11)Death (5)Multiple Drug Overdose Accidental (5)Pulmonary Congestion (5)Pulmonary Oedema (4)more >>


Page last updated: 2016-02-05

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015